Apixaban (BMS-562247-01) is a compound being investigated as an anticoagulant. Apixaban molecule is developed in a joint venture by Pfizer and Bristol-Myers Squibb. Apixaban, a coagulation factor Xa inhibitor, approved in the E.U. in 2011 for the prevention of venous thromboembolic events in ...
Aapixaban Impurity-A推荐供应商 建议您优先选择企业会员,我们对企业会员产品有严格审核。 公司名称:AKASH PHARMA EXPORTS推荐 联系电话:+91-9388123451 +91-9846039283 电子邮件:akashpharmaexports@gmail.com 国籍:印度 产品介绍:英文名称:Aapixaban Impurity-A ...
Apixaban (BMS-562247; 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide), a direct inhibitor of activated factor X (FXa), is in development for the prevention and treatment of various thromboembolic diseases. With...